MedTrace Logo

Safety and Efficacy of Stem Cell Transplantation for Treatment of Liver Cirrhosis

NCT01491165 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2012-10-26

No results posted yet for this study

Summary

Mainstream of current treatment of liver cirrhosis is liver transplantation, but there are high cost, risk and immune rejection and other issues. Umbilical cord mesenchyma stem cell with self-and directed differentiation capacity can effectively rescue experimental liver failure and contribute to liver regeneration, which suggests the feasibility of stem cell transplantation therapy. In this study, the safety and efficacy of umbilical cord mesenchyma stem cell transplantation through interventional procedures in patients liver cirrhosis will be evaluated.

Conditions

  • Other Surgical Procedures

Interventions

PROCEDURE

stem cell transplantation through interventional procedures

one time interventional procedures

Sponsors & Collaborators

  • Xinjiang Armed Police Corps Hospital

    collaborator UNKNOWN

  • Taian Hospital of Traditional Chinese Medicine

    collaborator UNKNOWN

  • General Hospital of Chinese Armed Police Forces

    lead OTHER

Principal Investigators

  • Yihua An · Department of Stem Cell Transplantation, the General Hospital of Chinese People's Armed Police Force

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-12-31
Primary Completion
2012-12-31
Completion
2014-06-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01491165 on ClinicalTrials.gov